Leicester Ozone Clinic
for Natural Therapies

​

Hydrogen gas (H₂) acts as a powerful antioxidant and anti-inflammatory agent, mechanisms which underpin its exploration as a supportive therapy in oncology and other conditions involving chronic inflammation and oxidative stress.  Unlike many antioxidants, it is administered by inhalation rather than injection and is highly selective, removing specific harmful oxidative stress agents without disrupting the overall balance between oxidation and antioxidants.

​

https://www.cancertreatmentsresearch.com/hydrogen/

​

Pioneered in Japan, hydrogen inhalation technology has been investigated for its potential to support patients with advanced cancer, as well as for general wellness and detoxification. The information below is derived from clinical research and case reports.

​

​

Key Research Findings in Supportive Oncology

1- Brain metastases disappear completely in non-small cell lung cancer by hydrogen gas inhalation, case report

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6927257/

​

2- A prospective follow-up study of 82 patients with stage III and IV cancer reported the following results after four weeks of hydrogen inhalation (https://pubmed.ncbi.nlm.nih.gov/31552873/):

• Improved Quality of Life: Patients reported significant improvements in fatigue, insomnia, anorexia, and pain.

• Enhanced Physical Fitness: 41.5% of patients experienced improved physical fitness, with the greatest improvements observed among lung cancer patients.

• Disease Control: Among 80 cases with visible tumours on imaging, the overall disease control rate was 57.5%. Complete and partial remissions appeared between 21 and 80 days (median 55 days) after starting inhalation. Disease control was notably higher in stage III patients (83.0%) compared to stage IV patients (47.7%).

A separate case report documented the complete disappearance of brain metastases in a patient with non-small cell lung cancer following hydrogen gas inhalation.

​

3- Hydrogen gas restores exhausted CD8+ T cells in patients with advanced colorectal cancer to improve prognosis

https://www.spandidos-publications.com/10.3892/or.2018.6841#

​

4- Hydrogen therapy can be used to control tumour progression and alleviate adverse drug events in patients with advanced non-small cell lung cancer.

https://pubmed.ncbi.nlm.nih.gov/32541132/

​

Administration and Safety

​

• Method: The most effective method is inhalation through nasal cannulas, similar to oxygen administration.

• Safety Profile: Hydrogen is considered very safe. In a study of 55 patients who inhaled hydrogen gas daily for three months, no adverse events were observed. Side effects are virtually nonexistent, even with continuous administration for 6 to 12 hours daily.

Cost

£75 per 45-minute therapy session.​​

Multiple sessions can be booked for an extended period, and they can be administered at the same time as other oncology support therapy if desired.